Press Release: Pulse8 : Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence platform

NASHVILLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm , an Allscripts (NASDAQ: MDRX) business unit, the first - and ONLY one with a patent pending - healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, proudly debuted several significant enhancements to its illumin8 Solution Suite this quarter - most notably, the advent of an ACO-specific module to their flagship risk adjustment solution as well as the implementation of Pulse Alerts across its customer base of innovative health plans and at-risk providers.